Navigation Links
Injectable Vaccines More Effective for Adult Flu Than Nasal Sprays
Date:9/23/2009

ing lab tests.

Participants who'd received the nasal spray vaccine were 36 percent less likely to get the flu than those who'd received a placebo.

The injection was 50 percent better in preventing the flu than the nasal spray, according to the study.

Though researchers did not test vaccines in children, nasal sprays may work just as well in children as injections, Monto said.

There are two different types of vaccines, usually referred to as live attenuated, which contain very weakened or modified live virus, and inactivated, which contain bits of dead virus.

Live attenuated influenza vaccine, which comes in nasal sprays, must replicate in the body in order to provoke the immune system to produce antibodies against the virus. In adults who may already have some immunity against that or other flu strains, the live attenuated virus may not be strong enough to cause that response, Monto said.

Children are more likely to lack antibodies to the virus. Without any natural immunity, the nasal spray may be equally effective, Monto said.

Live attenuated vaccines "must infect in order to protect," Monto said. "Adults, unlike children, have antibodies to the virus included in the vaccine. They are not infected by it and therefore are not protected. This would explain why the LAIV [live attenuated influenza vaccine] is highly effective in younger children."

In some cases, the live attenuated influenza vaccine may even provide enhanced protection, said Dr. Kenneth Bromberg, director of the Vaccine Research Center at the Brooklyn Hospital Center in New York City.

In addition to immunity involving antibodies, live attenuated vaccines can also provide cell-mediated immunity, an added type of immune response that can boost effectiveness.

"They are different approaches, and in the case of a well-matched strain, the inactivated vaccine worked better than the live attenuated," Bromberg
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
2. Injectable Antibiotic Protects Against Lyme Disease in Mice
3. Clarity on Cosmetic Injectable Labeling and Use
4. Dr. Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers
5. New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables
6. New Injectable Collagen Filler Offers Natural Results
7. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
8. Study finds injectable birth control causes significant weight gain and changes in body mass
9. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
10. Video: Injectable-Grade Filler, Now Without the Injections
11. Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Injectable Vaccines More Effective for Adult Flu Than Nasal Sprays
Injectable Vaccines More Effective for Adult Flu Than Nasal Sprays
(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...
(Date:12/15/2009)... Austrian researchers have successfully developed a new electrophoretic ... in the blood. The technique, using SARCOSYL-PAGE, ... not alter the performance characteristics of SDS-PAGE for ... funded by a grant from the World Anti-Doping ... Drug Testing and Analysis published by ...
(Date:12/15/2009)... Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization of technologies ... resolutions that the Company had proposed at the Annual General Meeting of Shareholders held on ... Votes ... Non-, Matter ... For Against ...
(Date:12/15/2009)... of America and the Saint Thomas, Lupus Trust ... son of the legendary John Lennon, and James Scott ... raise funds for research on the disease lupus. From ... proceeds from downloading "LUCY" at iTunes will be donated ... Saint Thomas, Lupus Trust in Great Britain. ,, Both ...
(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), a leading ... States, today announced that,it will host a conference call ... management to review the company,s third quarter results. ... conference call will be held on Wednesday, October,31, 2007 ...
... Injustice, Will Challenge,Corporate-Backed Proponents of "Health Courts", ... Nance, co-author of the groundbreaking new report on ... featured speakers at a,patient safety forum in Cheyenne, ... the merits and weaknesses of the health courts ...
... http://www.medikeeper.com ), a leading provider of technology solutions ... Series A investment round,led by Hawaii-based venture capital ... by a team of entrepreneurs and medical,professionals with ... accessible online. Beginning with its flagship Personal Health ...
... New T-Shirt Design Marks 2007 Race in San Diego, ... Komen San,Diego Race for the Cure(R) will be held in ... than three weeks until the Race, participants still,have two final ... http://www.komensandiego.org until Monday, October 22 or visit,Roadrunner Sports at ...
... Massachusetts,is not a model for California health reform, according ... to buy private health coverage.,Coverage in Massachusetts is already ... not capped or regulated, have indicated rates,will increase again ... Massachusetts law, which provides an,overview of the cost and ...
... the drugs are used with certain painkillers, study finds ... called selective serotonin reuptake inhibitors (SSRIs), which include Celexa, ... gastrointestinal bleeding, and the threat is more than six ... medications at the same time as SSRIs, a new ...
Other Medicine News:Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2Health News:MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor 2Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 2Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 3Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 2Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 3Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 4Health News:Antidepressants Boost GI Bleeding Risk 2
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...
(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
Breaking Medicine Technology:Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Americas Registered Nurses Applaud New Institute of Medicine H1N1 Swine Flu Safety Recommendations and Call on CDC to Maintain Stringent Safety Gui 56316 1Americas Registered Nurses Applaud New Institute of Medicine H1N1 Swine Flu Safety Recommendations and Call on CDC to Maintain Stringent Safety Gui 56316 2Single Parents May Do as Well as Two 3A Study 56314 1Single Parents May Do as Well as Two 3A Study 56314 2TrueShred Earns Industrys Highest Security Certification 56311 1
... sustained levels of drug reported after one treatmentLOUISVILLE, ... held biotechnology company developing medicines for the treatment ... it successfully completed its Phase I ASaP (Assessment ... with Neovascular Age-Related Macular Degeneration) clinical trial for ...
... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...
Other Medicine Technology:Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 2Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 3Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
... trabeculum provides the highest magnification of ANY gonioscopy ... treating the trabecular meshwork. One 62° mirror ... angle while the central portion of the lens ... for signs of glaucoma and other central retinal ...
The Mid Field 30° lens has a bi-concave design to provide a wider field of view with a 30 degree offset image....
... AFX Lens is a direct ... in an air-filled eye. In ... a primary air-fluid exchange vitrectomy ... sutureless design make it well ...
Medicine Products: